Sign in
4

Changes in Ownership

BioXcel Therapeutics, Inc. Filed Acc 0001104659-22-005451

Options or other derivatives

  • CHIEF COMMERCIAL OFFICER acquired 85,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wiley Matthew T. · CHIEF COMMERCIAL OFFICER

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-17 Grant or award : show line 1 in the form Stock Option (Right to Buy) +85,000 85,000 D
Loading xslF345X03/tm223835-2_4seq1.xml…